Mary-Margaret Keating, Tae Min Kim, Farrukh Awan, Jingxian Cai, Amulya Uppala, Aafia Chaudhry, Hesham Mohamed, Manjusha Namuduri, Jan Walewski. "Odronextamab treatment for patients with rare subtypes of relapsed/refractory (R/R) aggressive B-cell non-Hodgkin lymphoma (B-NHL): Updated efficacy and safety analyses from a dedicated cohort of the ELM-2 study." Blood, 2025. doi:10.1182/blood-2025-5523